Endocrinol Metab.  2014 Dec;29(4):489-497. 10.3803/EnM.2014.29.4.489.

Clinicopathological, Biochemical, and Sonographic Features of Thyroid Nodule Predictive of Malignancy among Adult Filipino Patients in a Tertiary Hospital in the Philippines

• Canete EJ
• Sison-Pena CM
• Jimeno CA

• KMID: 2384246
• DOI: http://doi.org/10.3803/EnM.2014.29.4.489

Abstract

BACKGROUND
Thyroid nodules may harbor cancer in 5% to 15% of cases. Specific clinical and sonographic features predictive of malignancy have been investigated in various populations, but due to differences in epidemiology, risk factors and iodine nutrition status, these predictors may not be valid in the Philippines. This study determined the clinicopathological, biochemical, and sonographic features of thyroid nodules predictive of malignancy among adult Filipino patients at the University of the Philippines-Philippine General Hospital (UP-PGH).
METHODS
We reviewed the medical records of Filipino patients > or =19 years of age who underwent thyroid surgery in UP-PGH from 2008 to 2011.
RESULTS
A total of 837 of 1,670 patients (50.1%) were enrolled in the study, which included 417 benign and 420 malignant tumors. The mean age at diagnosis was 38+/-11 years, with female predominance. Multiple logistic regression analysis showed that the presence of a hard or firm nodule (odds ratio [OR], 58.8, P<0.001; OR, 12.8, P<0.001), presence of microcalcifications (OR, 11.1; P<0.001), irregular margins on ultrasound (OR, 4.5; P<0.001), and absence of associated symptoms (OR, 2.3; P<0.002) increased significantly the likelihood of thyroid malignancy.
CONCLUSION
Similar to international data, the absence of associated symptoms, firm to hard thyroid nodules, and the presence of microcalcifications and irregular margins were significant predictors of thyroid malignancy.

Keyword

Thyroid nodule; Thyroid malignancy; Ultrasonography

MeSH Terms

Adult*
Diagnosis
Epidemiology
Female
Hospitals, General
Humans
Iodine
Logistic Models
Medical Records
Nutritional Status
Philippines*
Risk Factors
Tertiary Care Centers*
Thyroid Gland
Thyroid Nodule*
Ultrasonography*
Iodine

Reference

1. Singer PA, Cooper DS, Daniels GH, Ladenson PW, Greenspan FS, Levy EG, Braverman LE, Clark OH, McDougall IR, Ain KV, Dorfman SG. Treatment guidelines for patients with thyroid nodules and well-differentiated thyroid cancer: American Thyroid Association. Arch Intern Med. 1996; 156:2165–2172.

2. Vanderpump MP, Tunbridge WM, French JM, Appleton D, Bates D, Clark F, Grimley Evans J, Hasan DM, Rodgers H, Tunbridge F, Young ET. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol (Oxf). 1995; 43:55–68.

3. Usha Menon V, Sundaram KR, Unnikrishnan AG, Jayakumar RV, Nair V, Kumar H. High prevalence of undetected thyroid disorders in an iodine sufficient adult south Indian population. J Indian Med Assoc. 2009; 107:72–77.

4. Carlos-Raboca J, Jimeno CA, Kho SA, Andag-Silva AA, Jasul GV Jr, Nicodemus NA Jr, Cunanan EC, Duante CA. The Philippine Thyroid Diseases Study (PhilTiDeS 1): prevalence of thyroid disorders among adults in the Philippines. J Asean Fed Endocr Soc. 2012; 27:27–33.

5. American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Pacini F, Schlumberger M, Sherman SI, Steward DL, Tuttle RM. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009; 19:1167–1214.

6. Pacini F. Changing natural history of differentiated thyroid cancer. Endocrine. 2012; 42:229–230.

7. Kilfoy BA, Zheng T, Holford TR, Han X, Ward MH, Sjodin A, Zhang Y, Bai Y, Zhu C, Guo GL, Rothman N, Zhang Y. International patterns and trends in thyroid cancer incidence, 1973-2002. Cancer Causes Control. 2009; 20:525–531.

8. Laudico AV, Mirasol-Lumague MR, Mapua CA, Uy GB, Toral JA, Medina VM, Pukkala E. Cancer incidence and survival in Metro Manila and Rizal province, Philippines. Jpn J Clin Oncol. 2010; 40:603–612.

9. De La Pena AS. Thyroid cancer in the Philippines: an update. Acta Med Philipp. 1993; 29:38–42.

10. Department of Health (DOH). Department of Health Statistics [Internet]. Manila: Department of Health (DOH);1998. cited 2012 Apr 16. Available from: http://www.doh.gov.ph.

11. Haselkorn T, Stewart SL, Horn-Ross PL. Why are thyroid cancer rates so high in southeast asian women living in the United States? The bay area thyroid cancer study. Cancer Epidemiol Biomarkers Prev. 2003; 12:144–150.

12. British Thyroid Association. Royal College of Physicians of London. Guidelines for the management of thyroid cancer. 2nd ed. London: Royal College of Physicians [in association with] British Thyroid Association;2007.

13. Cobin RH, Gharib H, Bergman DA, Clark OH, Cooper DS, Daniels GH, Dickey RA, Duick DS, Garber JR, Hay ID, Kukora JS, Lando HM, Schorr AB, Zeiger MA. Thyroid Carcinoma Task Force. AACE/AAES medical/surgical guidelines for clinical practice: management of thyroid carcinoma: American Association of Clinical Endocrinologists: American College of Endocrinology. Endocr Pract. 2001; 7:202–220.

14. Pacini F, Castagna MG, Brilli L, Pentheroudakis G. ESMO Guidelines Working Group. Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2010; 21:Suppl 5. v214–v219.

15. Pacini F, Schlumberger M, Dralle H, Elisei R, Smit JWA, Wiersinga W. European Thyroid Cancer Taskforce. European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol. 2006; 154:787–803.

16. Hermosisima GO. Carcinoma of the thyroid: its prevalence in our area. Philipp J Surg Surg Spec. 1966; 21:270–273.

17. Purisima CO. A clinico-pathological analysis of surgical thyroid cases in the Veterans Memorial Hospital during a ten-year period (1961-1970). [place unknown]: HERDIN;2014. cited 2012 Apr 16. Available from: http://www.herdin.ph/index.php/component/herdin/?view=research&cid=31786.

18. Tipayno MJ. A comparative review on the prevalence of thyroid malignancy in the Cordillera and lowland regions. Philipp J Otolaryngol Head Neck Surg. 2002; 17:160–162.

19. Hermosisima GO. Carcinoma of the thyroid: its prevalence in our area. Philipp J Surg Surg Spec. 1966; 21:270–273.

20. Rivera NV, Lagman CV. The incidence of thyroid carcinoma and complications of thyroid surgery at Ospital ng Maynila: a five-year study [Internet]. [place unknown]: HERDIN;2014. cited 2012 Apr 16. Available from: http://www.herdin.ph/index.php/component/herdin/?view=research&cid=19469.

21. Laudico AV, Eufemio GG, Liquete MJ. Clinical Manifestation of thyroid carcinoma among Filipinos. Philipp J Surg Spec. 1979; 34:159–167.

22. Quiaoit SS, Jasul GV Jr, Quimpo JA. Thyroid function in thyroid carcinoma: a 5-year retrospective analysis. Phil J Int Med. 2009; 47:65–70.

23. Fish SA, Langer JE, Mandel SJ. Sonographic imaging of thyroid nodules and cervical lymph nodes. Endocrinol Metab Clin North Am. 2008; 37:401–417.

24. The Papanicolaou. Guidelines of the Papanicolaou Society of Cytopathology for fine-needle aspiration procedure and reporting. Diagn Cytopathol. 1997; 17:239–247.

25. Haymart MR, Repplinger DJ, Leverson GE, Elson DF, Sippel RS, Jaume JC, Chen H. Higher serum thyroid stimulating hormone level in thyroid nodule patients is associated with greater risks of differentiated thyroid cancer and advanced tumor stage. J Clin Endocrinol Metab. 2008; 93:809–814.